• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Eph 受体、神经纤毛蛋白-1、P2X7 和 CD147 在 COVID-19 相关神经退行性疾病中的作用:炎症小体和 Jak 抑制剂作为有前途的潜在治疗方法。

The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.

机构信息

American Association of Kidney Patients, Tampa, FL, USA.

Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1.

DOI:10.1186/s11658-022-00311-1
PMID:35109786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8809072/
Abstract

The novel coronavirus disease 2019 (COVID-19) pandemic has spread worldwide, and finding a safe therapeutic strategy and effective vaccine is critical to overcoming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, elucidation of pathogenesis mechanisms, especially entry routes of SARS-CoV-2 may help propose antiviral drugs and novel vaccines. Several receptors have been demonstrated for the interaction of spike (S) protein of SARS-CoV-2 with host cells, including angiotensin-converting enzyme (ACE2), ephrin ligands and Eph receptors, neuropilin 1 (NRP-1), P2X7, and CD147. The expression of these entry receptors in the central nervous system (CNS) may make the CNS prone to SARS-CoV-2 invasion, leading to neurodegenerative diseases. The present review provides potential pathological mechanisms of SARS-CoV-2 infection in the CNS, including entry receptors and cytokines involved in neuroinflammatory conditions. Moreover, it explains several neurodegenerative disorders associated with COVID-19. Finally, we suggest inflammasome and JaK inhibitors as potential therapeutic strategies for neurodegenerative diseases.

摘要

新型冠状病毒病 2019(COVID-19)大流行已在全球范围内蔓延,寻找安全的治疗策略和有效的疫苗对于克服严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)至关重要。因此,阐明发病机制,特别是 SARS-CoV-2 的进入途径可能有助于提出抗病毒药物和新型疫苗。已经证明有几种受体可用于 SARS-CoV-2 的刺突(S)蛋白与宿主细胞相互作用,包括血管紧张素转换酶(ACE2)、表皮生长因子配体和 Eph 受体、神经纤毛蛋白 1(NRP-1)、P2X7 和 CD147。这些进入受体在中枢神经系统(CNS)中的表达可能使 CNS 容易受到 SARS-CoV-2 的侵袭,导致神经退行性疾病。本综述提供了 SARS-CoV-2 感染 CNS 的潜在病理机制,包括参与神经炎症状态的进入受体和细胞因子。此外,还解释了与 COVID-19 相关的几种神经退行性疾病。最后,我们建议使用炎症小体和 JaK 抑制剂作为神经退行性疾病的潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd94/8903531/9dca1c15e88d/11658_2022_311_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd94/8903531/9dca1c15e88d/11658_2022_311_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd94/8903531/9dca1c15e88d/11658_2022_311_Fig1_HTML.jpg

相似文献

1
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.Eph 受体、神经纤毛蛋白-1、P2X7 和 CD147 在 COVID-19 相关神经退行性疾病中的作用:炎症小体和 Jak 抑制剂作为有前途的潜在治疗方法。
Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1.
2
Tumor markers as an entry for SARS-CoV-2 infection?肿瘤标志物是否可作为 SARS-CoV-2 感染的标志物?
FEBS J. 2020 Sep;287(17):3677-3680. doi: 10.1111/febs.15499. Epub 2020 Aug 28.
3
Role of host factors in SARS-CoV-2 entry.宿主因素在 SARS-CoV-2 进入中的作用。
J Biol Chem. 2021 Jul;297(1):100847. doi: 10.1016/j.jbc.2021.100847. Epub 2021 May 28.
4
An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.贝塔冠状病毒病毒进入抑制剂的最新综述:从过去的发现中吸取教训,推进 COVID-19 药物发现。
Curr Top Med Chem. 2021;21(7):571-596. doi: 10.2174/1568026621666210119111409.
5
DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.DNA 适体掩蔽血管紧张素转化酶 2 作为治疗 SARS-CoV-2 大流行的创新方法。
Pharmacol Res. 2022 Jan;175:105982. doi: 10.1016/j.phrs.2021.105982. Epub 2021 Nov 16.
6
SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.SARS-CoV-2 进入:CD147 和 ACE2 的十字路口。
Cells. 2021 Jun 8;10(6):1434. doi: 10.3390/cells10061434.
7
Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.经典和替代 SARS-CoV-2 治疗策略受体。
Rev Med Virol. 2021 Sep;31(5):1-9. doi: 10.1002/rmv.2207. Epub 2020 Dec 26.
8
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.CD147 抗体特异性且有效地抑制了 SARS-CoV-2 及其变异株 delta、alpha、beta 和 gamma 的感染和细胞因子风暴。
Signal Transduct Target Ther. 2021 Sep 25;6(1):347. doi: 10.1038/s41392-021-00760-8.
9
Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).宿主细胞进入介体参与 SARS-CoV-2 的细胞嗜性、COVID-19 的病理生理学以及鉴定可调节这些介体表达的 microRNAs(综述)。
Int J Mol Med. 2022 Feb;49(2). doi: 10.3892/ijmm.2021.5075. Epub 2021 Dec 22.
10
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.血管紧张素转换酶 2 和肾素血管紧张素系统抑制剂在 COVID-19 中的应用:最新进展。
High Blood Press Cardiovasc Prev. 2021 Mar;28(2):129-139. doi: 10.1007/s40292-021-00439-9. Epub 2021 Feb 26.

引用本文的文献

1
Infections with and SARS-CoV-2 and Alzheimer's disease pathogenesis.感染与新型冠状病毒 2 型以及阿尔茨海默病发病机制。 (注:原文中“with and SARS-CoV-2”表述不太完整准确,推测可能是想说“with SARS-CoV-2”之类的,但按照要求完整翻译此句如上)
Front Aging Neurosci. 2025 Jun 13;17:1587782. doi: 10.3389/fnagi.2025.1587782. eCollection 2025.
2
Trends in Research on the P2X7 Receptor: A Bibliometric and Visualization Analysis.P2X7受体的研究趋势:文献计量学与可视化分析
J Inflamm Res. 2025 May 16;18:6349-6362. doi: 10.2147/JIR.S522380. eCollection 2025.
3
Neuropilin-1 as a Neuroinflammatory Entry Factor for SARS-CoV-2 Is Attenuated in Vaccinated COVID-19 Patients: A Case-Control Study.

本文引用的文献

1
The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy.PI3K/AKT 信号通路在 SARS-CoV-2 诱导的凝血功能障碍中的可能作用和治疗潜力。
Cell Mol Biol Lett. 2022 Jan 11;27(1):6. doi: 10.1186/s11658-022-00308-w.
2
Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.SARS-CoV-2 奥密克戎变异株 RBD 上的突变导致其与人类 ACE2 受体更强的结合。
Biochem Biophys Res Commun. 2022 Jan 29;590:34-41. doi: 10.1016/j.bbrc.2021.12.079. Epub 2021 Dec 24.
3
Impact of COVID-19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research.
在接种疫苗的新冠肺炎患者中,作为SARS-CoV-2神经炎症进入因子的神经纤毛蛋白-1减弱:一项病例对照研究。
Health Sci Rep. 2025 Apr 7;8(4):e70630. doi: 10.1002/hsr2.70630. eCollection 2025 Apr.
4
Cognitive Sequelae of COVID-19: Mechanistic Insights and Therapeutic Approaches.新冠病毒病的认知后遗症:机制洞察与治疗方法
CNS Neurosci Ther. 2025 Mar;31(3):e70348. doi: 10.1111/cns.70348.
5
Hypoxia signaling in cancer: HIF-1α stimulated by COVID-19 can lead to cancer progression and chemo-resistance in oral squamous cell carcinoma (OSCC).癌症中的缺氧信号传导:由新冠病毒(COVID-19)刺激的缺氧诱导因子-1α(HIF-1α)可导致口腔鳞状细胞癌(OSCC)的癌症进展和化疗耐药性。
Discov Oncol. 2025 Mar 26;16(1):399. doi: 10.1007/s12672-025-02150-w.
6
Leveraging Artificial Intelligence and Gene Expression Analysis to Identify Some Potential Bovine Coronavirus (BCoV) Receptors and Host Cell Enzymes Potentially Involved in the Viral Replication and Tissue Tropism.利用人工智能和基因表达分析来鉴定一些潜在的牛冠状病毒(BCoV)受体以及可能参与病毒复制和组织嗜性的宿主细胞酶。
Int J Mol Sci. 2025 Feb 4;26(3):1328. doi: 10.3390/ijms26031328.
7
Neurological Impact of Respiratory Viruses: Insights into Glial Cell Responses in the Central Nervous System.呼吸道病毒的神经学影响:对中枢神经系统中神经胶质细胞反应的见解
Microorganisms. 2024 Aug 20;12(8):1713. doi: 10.3390/microorganisms12081713.
8
Impact of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review.严重急性呼吸综合征冠状病毒2刺突蛋白对固有免疫系统的影响:综述
Cureus. 2024 Mar 26;16(3):e57008. doi: 10.7759/cureus.57008. eCollection 2024 Mar.
9
CHRNA9 as a New Prognostic Marker and Potential Therapeutic Target in Glioma.CHRNA9作为胶质瘤新的预后标志物和潜在治疗靶点
J Cancer. 2024 Feb 24;15(8):2095-2109. doi: 10.7150/jca.92080. eCollection 2024.
10
Unique tRNA Fragment Upregulation with SARS-CoV-2 but Not with SARS-CoV Infection.新冠病毒而非非典病毒感染可导致独特的 tRNA 片段上调。
Int J Mol Sci. 2023 Dec 28;25(1):399. doi: 10.3390/ijms25010399.
新冠疫情对阿尔茨海默病及相关痴呆的发病和进展的影响:未来研究的路线图。
Alzheimers Dement. 2022 May;18(5):1038-1046. doi: 10.1002/alz.12488. Epub 2021 Dec 7.
4
SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration.SARS-CoV-2 跨越血脑屏障伴随着基膜破坏而没有紧密连接的改变。
Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.
5
Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.高致病性人类冠状病毒刺突受体结合基序的预测结构模拟
Comput Struct Biotechnol J. 2021 Jul 2;19:3938-3953. doi: 10.1016/j.csbj.2021.06.041. eCollection 2021.
6
Targeting neuropilins as a viable SARS-CoV-2 treatment.针对神经纤毛蛋白作为一种可行的 SARS-CoV-2 治疗方法。
FEBS J. 2021 Sep;288(17):5122-5129. doi: 10.1111/febs.16096. Epub 2021 Jul 12.
7
Dysregulation of brain and choroid plexus cell types in severe COVID-19.重症 COVID-19 中脑和脉络丛细胞类型的失调。
Nature. 2021 Jul;595(7868):565-571. doi: 10.1038/s41586-021-03710-0. Epub 2021 Jun 21.
8
Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19.在新冠病毒疾病中,埃菲林-A1和去整合素金属蛋白酶12上调。
Heliyon. 2021 Jun;7(6):e07200. doi: 10.1016/j.heliyon.2021.e07200. Epub 2021 May 31.
9
Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic.新冠疫情期间胶质母细胞瘤治疗中的肿瘤治疗电场
Front Oncol. 2021 May 7;11:679702. doi: 10.3389/fonc.2021.679702. eCollection 2021.
10
Evidence for residual SARS-CoV-2 in glioblastoma tissue of a convalescent patient.恢复期患者脑胶质母细胞瘤组织中存在 SARS-CoV-2 的证据。
Neuroreport. 2021 Jun 9;32(9):771-775. doi: 10.1097/WNR.0000000000001654.